Clinical Trials
159
Active:60
Completed:90
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:86
Phase 2:14
+3 more phases
Drug Approvals
3
SFDA:3
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (126 trials with phase data)• Click on a phase to view related trials
Phase 1
86 (68.3%)Phase 2
14 (11.1%)Phase 4
9 (7.1%)Not Applicable
8 (6.3%)Phase 3
8 (6.3%)Early Phase 1
1 (0.8%)Efficacy and Tolerability of Tasipimidine in Sleepless Patients
Phase 2
Active, not recruiting
- Conditions
- Insomnia
- Interventions
- Drug: Tasipimidine placebo
- First Posted Date
- 2025-05-04
- Last Posted Date
- 2025-08-17
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 153
- Registration Number
- NCT06956495
- Locations
- 🇫🇮
Terveystalo Helsinki Uniklinikka, Helsinki, Finland
Two-part, First-in-Human Study on ODM-212 in Subjects with Selected Advanced Solid Tumours
- First Posted Date
- 2024-12-10
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 315
- Registration Number
- NCT06725758
- Locations
- 🇬🇧
Royal Marsden Hospital, London, UK, London, United Kingdom
Efficacy and Safety of Remo-Wax® Oil (RWO) in Subjects With Isolated Itching of the External Ear Canal
Not Applicable
Completed
- Conditions
- Itching
- First Posted Date
- 2023-04-13
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 36
- Registration Number
- NCT05811039
- Locations
- 🇱🇹
Vilnius University Hospital, Vilnius, Lithuania
Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference Product
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: Indacaterol/glycopyrronium
- First Posted Date
- 2022-03-18
- Last Posted Date
- 2022-07-13
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 24
- Registration Number
- NCT05288075
- Locations
- 🇫🇮
CRST Helsinki Oy, Helsinki, Finland
Comparison of Tiotropium Absorption From Tiotropium Easyhaler and Spiriva HandiHaler
- First Posted Date
- 2022-02-18
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 88
- Registration Number
- NCT05246046
- Locations
- 🇫🇮
Clinical Pharmacology Unit, Orion Corporation, Espoo, Finland
- Prev
- 1
- 2
- 3
- 4
- 5
- 20
- Next
News
No news found